Effects of 10 Hz repetitive transcranial magnetic stimulation (rTMS) on clinical global impression in chronic schizophrenia

Psychiatry Research

Volumn 177, Issue 1-2, 2010, Pages 32-36

  Cordes, Joachim ^a   Thünker, Johanna ^a   Agelink, Marcus W ^b   Arends, Mareke ^a   Mobascher, Arian ^a   Wobrock, Thomas ^c   Schneider Axmann, Thomas ^c   Brinkmeyer, Jürgen ^a   Mittrach, Margarethe ^a   Regenbrecht, Gunnar ^a   Wölwer, Wolfgang ^a   Winterer, Georg ^a   Gaebel, Wolfgang ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Clinical global impression; Repetitive transcranial magnetic stimulation; Schizophrenia

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PERAZINE; PIPAMPERONE; QUETIAPINE; RISPERIDONE; VALPROIC ACID; ZIPRASIDONE;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EARLY INTERVENTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR CORTEX; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANALYSIS OF VARIANCE; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STATISTICS AS TOPIC; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 77952091731     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.01.014     Document Type: Article

References (35)

1. Andreasen N.C. Linking mind and brain in the study of mental illnesses: a project for a scientific psychopathology. Science 1997, 275(5306):1586-1593.
2. Aleman A., Sommer I.E., Kahn R.S. Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis. Journal of Clinical Psychiatry 2007, 68(3):416-421.
3. Cohen J. A power primer. Psychological Bulletin 1992, 112:155-159.
4. Conca A., Peschina W., Konig P., Fritzsche H., Hausmann A. Effect of chronic repetitive transcranial magnetic stimulation on regional cerebral blood flow and regional cerebral glucose uptake in drug treatment-resistant depressives. A brief report. Neuropsychobiology 2002, 45(1):27-31.
5. Cordes J., Arends M., Mobascher A., Brinkmeyer J., Kornischka J., Eichhammer P., Klimke A., Winterer G., Agelink M.W. Potential clinical targets of repetitive transcranial magnetic stimulation treatment in schizophrenia. Neuropsychobiology 2006, 54(2):87-99.
6. Emsley R., Rabinowitz J., Torreman M. RIS-INT-35 early psychosis global working group. The factor structure for the positive and negative syndrome scale (PANSS) in recent-onset psychosis. Schizophrenia Research 2003, 61(1):47-57.
7. Feinsod M., Kreinin B., Chistyakov A., Klein E. Preliminary evidence for a beneficial effect of low-frequency, repetitive transcranial magnetic stimulation in patients with major depression and schizophrenia. Depression and Anxiety 1998, 7(2):65-68.
8. Fox P., Ingham R., George M.S., Mayberg H., Ingham J., Roby J., Martin C., Jerabek P. Imaging human intra-cerebral connectivity by PET during TMS. Neuroreport 1997, 18, 8(12):2787-2791.
9. Goyal N., Nizamie S.H., Desarkar P. Efficacy of adjuvant high frequency repetitive transcranial magnetic stimulation on negative and positive symptoms of schizophrenia: preliminary results of a double-blind sham-controlled study. Journal of Neuropsychiatry and Clinical Neurosciences 2007, 19(4):464-467.
10. Guy W. ECDEU assessment manual for psychopharmacology. Rockville, MD, US Department of Health and Human Services Publication (ADM) 1976, 218-222.
11. Hajak G., Marienhagen J., Langguth B., Werner S., Binder H., Eichhammer P. High-frequency repetitive transcranial magnetic stimulation in schizophrenia: a combined treatment and neuroimaging study. Psychological Medicine 2004, 34(7):1157-1163.
12. Hill K., Mann L., Laws K.R., Stephenson C.M., Nimmo-Smith I., McKenna P.J. Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies. Acta Psychiatrica Scandinavica 2004, 110:243-256.
13. Hiller W., Zaudig M., Mombour W. Internationale Diagnose Checkliste für DSM-IV (IDCL) 1997, Hogrefe.
14. Hoffmann R.E., Boutros N.N., Hu S., Berman R.M., Krystal J.H., Charney D.S. Transcranial magnetic stimulation and auditory hallucinations in schizophrenia. Lancet 2000, 355(9209):1073-1075.
15. Holi M.M., Eronen M., Toivonen K., Toivonen P., Marttunen M., Naukkarinen H. Left prefrontal repetitive transcranial magnetic stimulation in schizophrenia. Schizophrenia Bulletin 2004, 30(2):429-434.
16. Jandl M., Bittner R., Sack A., Weber B., Gunther T., Pieschl D., Kaschka W.P., Maurer K. Changes in negative symptoms and EEG in schizophrenic patients after repetitive transcranial magnetic stimulation (rTMS): an open-label pilot study. Journal of Neural Transmission 2005, 112(7):955-967.
17. Jin Y., Potkin S.G., Kemp A.S., Huerta S.T., Alva G., Thai T.M., Carreon D., Bunney W.E. Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation ({alpha}TMS) on the negative symptoms of schizophrenia. Schizophrenia Bulletin 2006, 32(3):556-561.
18. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
19. Kimbrell T.A., Little J.T., Dunn R.T., Frye M.A., Greenberg B.D., Wassermann E.M., Repella J.D., Danielson A.L., Willis M.W., Benson B.E., Speer A.M., Osuch E., George M.S., Post R.M. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biological Psychiatry 1999, 15, 46(12):1603-1613.
20. Klein E., Kolsky Y., Puyerovsky M., Koren D., Chistyakov A., Feinsod M. Right prefrontal slow repetitive magnetic stimulation in schizophrenia: a double-blind sham-controlled pilot study. Biological Psychiatry 1999, 46:1451-1454.
21. Lisanby S.H., Gutman D., Luber B., Schroeder C., Sackeim H.A. Sham TMS: intracerebral measurement of the induced electrical field and the induction of motor-evoked potentials. Biological Psychiatry 2001, 49(5):460-463.
22. Loo C.K., Mitchell P.B. A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression and current and future strategies to optimize efficacy. Journal of Affective Disorders 2005, 88(3):255-267.
23. Marder S.R., Davis J.M., Chouinard G. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. Journal of Clinical Psychiatry 1997, 58(12):538-546.
24. Mogg A., Purvis R., Eranti S., Contell F., Taylor J.P., Nicholson T., Brown R.G., McLoughlin D.M. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: a randomized controlled pilot study. Schizophrenia Research 2007, 93(1-3):221-228.
25. Moos R.H., McCoy L., Moos B.S. Global assessment of functioning (GAF) ratings: determinants and role as predictors of one-year treatment outcomes. Journal of Clinical Psychology 2000, 56(4):449-461.
26. Nahas Z., Molloy M., Risch S.C., George M.S. TMS in schizophrenia. Transcranial Magnetic Stimulation In Neuropsychiatry 2000, 237-252. American Psychiatric Press, Washington, DC. M.S. George, R.H. Belmaker (Eds.).
27. Novak T., Horacek J., Mohr P., Kopecek M., Klirova M., Rodriguez M., Spaniel F., Dockery C., Hoschl C. The double-blind sham-controlled study of high-frequency rTMS (20 Hz) for negative symptoms in schizophrenia: negative results. Neuroendocrinology Letters 2006, 27(1-2):209-213.
28. Prikryl R., Kasparek T., Skotakova S., Ustohal L., Kucerova H., Ceskova E. Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study. Schizophrenia Research 2007, 95(1-3):151-157.
29. Rabinowitz J., Mehnert A., Eerdekens M. To what extent do the PANSS and CGI-S overlap?. Journal of Clinical Psychopharmacology 2006, 26(3):303-307.
30. Rollnik J.D., Huber T.J., Mogk H., Siggelkow S., Kropp S., Dengler R., Emrich H.M., Schneider U. High frequency repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex in schizophrenic patients. Neuroreport 2000, 11(18):4013-4015.
31. Rossi S., Ferro M., Cincotta M., Ulivelli M., Bartalini S., Miniussi C., Giovannelli F., Passero S. A real electro-magnetic placebo (REMP) device for sham transcranial magnetic stimulation (TMS). Clinical Neurophysiology 2007, 118(3):709-716.
32. Sachdev P., Loo C., Mitchell P., Malhi G. Transcranial magnetic stimulation for the deficit syndrome of schizophrenia: a pilot investigation. Psychiatry and Clinical Neuroscience 2005, 59(3):354-357.
33. Sechter D., Peuskens J., Fleurot O., Rein W., Lecrubier Y. Amisulpride versus risperidone in chronic schizophrenia: results of a 6-month double-blind study. Neuropsychopharmacology 2002, 27:1071-1081. The Amisulpride Study Group.
34. Strafella A.P., Paus T., Barrett J., Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudatus nucleus. Journal of Neuroscience 2001, 21(15):RC157.
35. Weinberger D.R., Berman K.F., Chase T.N. Mesocortical Dopaminergic Function and Human Cognition 1988, Vol. 537:330-338. New York Academy of Sciences, New York.